PERPHENAZINE

PERPHENAZINE was reported 2087 times

PERPHENAZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 150 0.2171
1 EPILEPSIA PARTIALIS CONTINUA 6 0.1429
2 MITOCHONDRIAL ENCEPHALOMYOPATHY 9 0.1268
3 PRESBYACUSIS 37 0.1201
4 DISINHIBITION 149 0.0925
5 ANGIOTENSIN CONVERTING ENZYME DECREASED 1 0.0588
6 PLEURAL THICKENING 37 0.0541
7 CREATININE RENAL CLEARANCE INCREASED 40 0.0535
8 AMPUTATION OF PENIS 1 0.0500
9 ANTIPSYCHOTIC DRUG LEVEL 1 0.0476
10 MULTIPLE DRUG THERAPY 34 0.0451
11 BLOOD MAGNESIUM INCREASED 38 0.0421
12 IDEAS OF REFERENCE 4 0.0392
13 PLEURAL FIBROSIS 38 0.0373
14 BONE HYPERTROPHY 6 0.0373
15 THERAPEUTIC PRODUCT EFFECT VARIABLE 141 0.0363
16 ADMINISTRATION SITE ABSCESS 1 0.0294
17 AMINO ACID METABOLISM DISORDER 1 0.0256
18 APRAXIA 37 0.0249
19 DENTAL PULP DISORDER 2 0.0235
20 HEAD TITUBATION 29 0.0211
21 OBSESSIVE-COMPULSIVE DISORDER 164 0.0204
22 SEDATION COMPLICATION 52 0.0204
23 POSTOPERATIVE DELIRIUM 4 0.0202
24 YERSINIA INFECTION 2 0.0196
25 SCHIZOAFFECTIVE DISORDER 34 0.0190
26 ADJUSTED CALCIUM INCREASED 1 0.0189
27 ONYCHOPHAGIA 5 0.0181
28 HAEMOCONCENTRATION 3 0.0173
29 DYSLIPIDAEMIA 85 0.0167
30 EUPHORIC MOOD 154 0.0150
31 PATIENT UNCOOPERATIVE 7 0.0148
32 BONE CYST 13 0.0139
33 AKATHISIA 186 0.0136
34 CONGENITAL TRICUSPID VALVE ATRESIA 2 0.0133
35 TYPE III IMMUNE COMPLEX MEDIATED REACTION 7 0.0125
36 ASPERGER'S DISORDER 1 0.0125
37 ASOCIAL BEHAVIOUR 4 0.0124
38 CREATININE RENAL CLEARANCE DECREASED 48 0.0120
39 DEAFNESS NEUROSENSORY 37 0.0112
40 CARDIOLIPIN ANTIBODY POSITIVE 2 0.0109
41 RENAL FUNCTION TEST ABNORMAL 47 0.0101
42 EPIGASTRIC DISCOMFORT 37 0.0095
43 REBOUND PSYCHOSIS 2 0.0094
44 HISTOLOGY ABNORMAL 2 0.0090
45 OSTEOSCLEROSIS 14 0.0089
46 LEUKAEMIA 83 0.0088
47 PARKINSONISM 85 0.0087
48 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST POSITIVE 1 0.0084
49 INCREASED APPETITE 156 0.0082
50 SPONTANEOUS PENILE ERECTION 5 0.0081
51 MYOCARDIAL OEDEMA 3 0.0076
52 JEALOUS DELUSION 2 0.0071
53 ABULIA 6 0.0065
54 POLYDIPSIA 25 0.0063
55 OBESITY 94 0.0059
56 SOLILOQUY 5 0.0058
57 BLOOD GLUCOSE 1 0.0056
58 ARTERIAL INSUFFICIENCY 1 0.0054
59 GENERALISED BULLOUS FIXED DRUG ERUPTION 2 0.0054
60 FACIAL ASYMMETRY 5 0.0052
61 NEUROLEPTIC MALIGNANT SYNDROME 62 0.0052
62 HYPERAMMONAEMIC ENCEPHALOPATHY 9 0.0052
63 MYOCLONUS 61 0.0051
64 BALLISMUS 1 0.0051
65 DYSMETRIA 3 0.0050
66 ILEUS PARALYTIC 21 0.0047
67 BLOOD CALCIUM DECREASED 51 0.0045
68 DYSTONIA 86 0.0044
69 NEUROSIS 2 0.0044
70 SOFT TISSUE MASS 2 0.0043
71 HYPERPROLACTINAEMIA 28 0.0043
72 TONGUE PARALYSIS 3 0.0042
73 ENURESIS 17 0.0042
74 BIOPSY SKIN ABNORMAL 1 0.0042
75 VERBAL ABUSE 2 0.0041
76 PYURIA 4 0.0040
77 HYPERTHERMIA MALIGNANT 6 0.0040
78 PRESCRIBED OVERDOSE 76 0.0039
79 GENITAL HYPOAESTHESIA 4 0.0039
80 POOR PERSONAL HYGIENE 2 0.0039
81 BLOOD ALCOHOL INCREASED 3 0.0038
82 TARDIVE DYSKINESIA 101 0.0036
83 ANTIPSYCHOTIC DRUG LEVEL INCREASED 10 0.0035
84 DRUG EFFECT VARIABLE 4 0.0035
85 NEPHROGENIC DIABETES INSIPIDUS 4 0.0035
86 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 2 0.0034
87 ORTHOSTATIC HYPOTENSION 60 0.0034
88 LYMPHATIC DISORDER 2 0.0034
89 GINGIVAL HYPERPLASIA 2 0.0033
90 PRIAPISM 11 0.0032
91 CYST 39 0.0031
92 NASAL SEPTUM PERFORATION 2 0.0031
93 SPINAL CORD INFECTION 2 0.0031
94 CONTINUOUS HAEMODIAFILTRATION 3 0.0031
95 ACANTHOSIS 1 0.0030
96 METABOLIC SYNDROME 5 0.0030
97 SUICIDE ATTEMPT 183 0.0030
98 GAMBLING DISORDER 8 0.0030
99 REDUCED FACIAL EXPRESSION 3 0.0030
100 SEDATION 76 0.0029
101 BORDERLINE PERSONALITY DISORDER 2 0.0028
102 LEUKOPENIA 140 0.0028
103 NASAL INJURY 2 0.0028
104 EXCESSIVE EYE BLINKING 4 0.0027
105 OSTEOPENIA 40 0.0026
106 QRS AXIS ABNORMAL 2 0.0026
107 ADMINISTRATION SITE REACTION 1 0.0026
108 DISTURBANCE IN SOCIAL BEHAVIOUR 6 0.0025
109 FULL BLOOD COUNT INCREASED 3 0.0025
110 CEREBRAL ATROPHY 10 0.0025
111 BLOOD URIC ACID ABNORMAL 1 0.0025
112 ACUTE PSYCHOSIS 6 0.0024
113 LUNG OPERATION 2 0.0024
114 ALVEOLAR OSTEITIS 1 0.0024
115 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 3 0.0023
116 BLOOD POTASSIUM INCREASED 38 0.0023
117 BLOOD ALBUMIN INCREASED 2 0.0022
118 DEFORMITY 21 0.0022
119 DYSKINESIA 91 0.0022
120 BANKRUPTCY 1 0.0022
121 RIGHT VENTRICULAR HYPERTROPHY 2 0.0022
122 EXTRAPYRAMIDAL DISORDER 55 0.0022
123 DRUG LEVEL BELOW THERAPEUTIC 12 0.0022
124 SALIVARY HYPERSECRETION 21 0.0021
125 CEREBELLAR ATAXIA 2 0.0021
126 ACTINOMYCOSIS 2 0.0021
127 BONE DEBRIDEMENT 1 0.0021
128 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 146 0.0021
129 NEGATIVE THOUGHTS 6 0.0020
130 ARTIFICIAL CROWN PROCEDURE 1 0.0020
131 BRAIN HERNIATION 6 0.0020
132 ANTISOCIAL BEHAVIOUR 2 0.0020
133 ATRIOVENTRICULAR BLOCK 15 0.0019
134 BREAST DISCOMFORT 2 0.0019
135 PSYCHOTIC SYMPTOM 4 0.0019
136 MULTIPLE-DRUG RESISTANCE 6 0.0019
137 GRANULOCYTOPENIA 11 0.0019
138 JOINT SPRAIN 2 0.0019
139 CATATONIA 10 0.0019
140 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
141 ANTIPSYCHOTIC DRUG LEVEL DECREASED 1 0.0019
142 INNER EAR DISORDER 2 0.0019
143 DIABETIC COMA 5 0.0018
144 GAZE PALSY 3 0.0018
145 SICK SINUS SYNDROME 2 0.0017
146 FLAT AFFECT 4 0.0017
147 GALACTORRHOEA 11 0.0017
148 HALLUCINATION, AUDITORY 27 0.0017
149 TOXICITY TO VARIOUS AGENTS 286 0.0017
150 ALLERGY TO METALS 1 0.0016
151 DROOLING 11 0.0016
152 BACILLUS INFECTION 1 0.0016
153 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
154 DEPRESSED LEVEL OF CONSCIOUSNESS 62 0.0016
155 PETIT MAL EPILEPSY 8 0.0016
156 METABOLIC DISORDER 9 0.0015
157 STRESS CARDIOMYOPATHY 9 0.0015
158 ALCOHOL INTERACTION 3 0.0015
159 SINUS ARRHYTHMIA 2 0.0015
160 EXOSTOSIS 14 0.0015
161 ANISOCYTOSIS 1 0.0015
162 BLADDER DISORDER 15 0.0015
163 THERAPEUTIC AGENT TOXICITY 5 0.0015
164 BODY MASS INDEX INCREASED 2 0.0015
165 HYPERURICAEMIA 6 0.0015
166 COMPULSIVE SHOPPING 3 0.0015
167 POLYCYTHAEMIA 3 0.0015
168 IMPAIRED SELF-CARE 3 0.0014
169 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
170 SKIN LESION 39 0.0014
171 TORTICOLLIS 3 0.0014
172 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 2 0.0014
173 DIABETES MELLITUS NON-INSULIN-DEPENDENT 2 0.0014
174 ACCOMMODATION DISORDER 1 0.0014
175 ATROPHIC VULVOVAGINITIS 1 0.0014
176 CEREBELLAR SYNDROME 3 0.0014
177 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
178 HYPERCAPNIA 4 0.0013
179 REBOUND ACID HYPERSECRETION 4 0.0013
180 MYOGLOBIN BLOOD INCREASED 2 0.0013
181 ANOSOGNOSIA 1 0.0013
182 ASPIRATION PLEURAL CAVITY 1 0.0013
183 HYPOTHERMIA 13 0.0013
184 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
185 MANIA 21 0.0013
186 COGNITIVE DISORDER 59 0.0013
187 INAPPROPRIATE AFFECT 2 0.0013
188 URINARY HESITATION 3 0.0013
189 MUSCLE RIGIDITY 15 0.0013
190 MULTIPLE DRUG OVERDOSE INTENTIONAL 4 0.0012
191 MOVEMENT DISORDER 39 0.0012
192 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
193 TROPONIN I INCREASED 2 0.0012
194 DEMENTIA ALZHEIMER'S TYPE 2 0.0012
195 EXPOSURE VIA INGESTION 3 0.0012
196 BRADYKINESIA 7 0.0012
197 PSYCHOTIC DISORDER 35 0.0012
198 SLEEP TALKING 2 0.0012
199 TRISMUS 6 0.0012
200 BLOOD PROLACTIN ABNORMAL 1 0.0012
201 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
202 BREAST DISCHARGE 2 0.0011
203 IRRITABILITY 68 0.0011
204 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 1 0.0011
205 OBSESSIVE THOUGHTS 2 0.0011
206 CLUMSINESS 3 0.0011
207 BODY TEMPERATURE ABNORMAL 2 0.0011
208 DISORGANISED SPEECH 2 0.0011
209 SCHIZOPHRENIA 13 0.0011
210 COMPLETED SUICIDE 88 0.0011
211 PANCREATIC CYST 2 0.0010
212 AGITATION NEONATAL 1 0.0010
213 PHARYNGEAL DISORDER 3 0.0010
214 OSTEOARTHRITIS 44 0.0010
215 BLOOD URINE 1 0.0010
216 TRAUMATIC LUNG INJURY 2 0.0010
217 PURULENCE 2 0.0010
218 OCCULT BLOOD POSITIVE 2 0.0010
219 HEPATOMEGALY 10 0.0010
220 MULTIPLE DRUG OVERDOSE 5 0.0010
221 HYPERNATRAEMIA 5 0.0010
222 WEIGHT INCREASED 224 0.0010
223 HYPERAMMONAEMIA 5 0.0010
224 ARTERIOSPASM CORONARY 4 0.0010
225 SEROTONIN SYNDROME 19 0.0010
226 INJECTION SITE NECROSIS 2 0.0010
227 SPINA BIFIDA 2 0.0010
228 PHYSICAL ASSAULT 2 0.0010
229 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
230 EYE CONTUSION 2 0.0009
231 ASTERIXIS 1 0.0009
232 ALLERGY TO ANIMAL 1 0.0009
233 LYMPHOCYTOSIS 2 0.0009
234 BLADDER DILATATION 1 0.0009
235 ACARODERMATITIS 1 0.0009
236 BIPOLAR I DISORDER 2 0.0009
237 MOBILITY DECREASED 65 0.0009
238 PEPTIC ULCER 3 0.0009
239 BLOODY DISCHARGE 1 0.0009
240 PARANOIA 15 0.0009
241 MENTAL STATUS CHANGES 24 0.0009
242 HYPERREFLEXIA 3 0.0009
243 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
244 BLOOD PROLACTIN INCREASED 4 0.0008
245 HEART DISEASE CONGENITAL 3 0.0008
246 FACIAL PARESIS 3 0.0008
247 PULMONARY INFARCTION 2 0.0008
248 DELUSION 13 0.0008
249 DRUG INTERACTION 132 0.0008
250 PANIC REACTION 6 0.0008
251 STILLBIRTH 4 0.0008
252 DEMENTIA 23 0.0008
253 TENSION 5 0.0008
254 BREATH ODOUR 2 0.0008
255 HYPOMANIA 3 0.0008
256 HYPERVOLAEMIA 4 0.0008
257 DIABETIC NEUROPATHY 4 0.0008
258 BLOOD UREA DECREASED 1 0.0008
259 TYPE 2 DIABETES MELLITUS 27 0.0008
260 DRY EYE 40 0.0008
261 HYPONATRAEMIA 45 0.0008
262 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
263 CONTRAINDICATED PRODUCT ADMINISTERED 24 0.0008
264 BRAIN OEDEMA 10 0.0008
265 BAND SENSATION 1 0.0008
266 EXCORIATION 2 0.0008
267 HAEMODYNAMIC INSTABILITY 6 0.0008
268 DIABETIC COMPLICATION 2 0.0008
269 BLOOD CREATININE INCREASED 51 0.0008
270 LOSS OF LIBIDO 7 0.0008
271 MEDICATION RESIDUE 2 0.0008
272 BLOOD CHLORIDE DECREASED 2 0.0008
273 ELECTROLYTE IMBALANCE 9 0.0008
274 ENCEPHALOPATHY 19 0.0008
275 THERAPY PARTIAL RESPONDER 12 0.0008
276 BRADYPHRENIA 5 0.0008
277 ADVERSE REACTION 10 0.0008
278 APATHY 11 0.0008
279 DRUG ABUSE 62 0.0007
280 NEUROTOXICITY 13 0.0007
281 CLONUS 2 0.0007
282 ABSCESS ORAL 1 0.0007
283 PHOTOSENSITIVITY REACTION 12 0.0007
284 ECONOMIC PROBLEM 11 0.0007
285 LUNG CONSOLIDATION 2 0.0007
286 PROCTITIS 2 0.0007
287 URINARY INCONTINENCE 21 0.0007
288 BALANCE DISORDER 61 0.0007
289 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
290 IMMOBILE 3 0.0007
291 TOOTH DISCOLOURATION 2 0.0007
292 BLOOD CREATINE INCREASED 3 0.0007
293 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
294 AGITATION 49 0.0007
295 TYPE 1 DIABETES MELLITUS 4 0.0007
296 HEPATITIS CHOLESTATIC 4 0.0007
297 CEREBROVASCULAR DISORDER 2 0.0007
298 LOSS OF EMPLOYMENT 2 0.0007
299 SELF INJURIOUS BEHAVIOUR 2 0.0007
300 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
301 BIPOLAR DISORDER 7 0.0006
302 UMBILICAL HERNIA 3 0.0006
303 PRE-EXISTING CONDITION IMPROVED 4 0.0006
304 SUSPECTED SUICIDE 3 0.0006
305 PRODUCT USE IN UNAPPROVED INDICATION 157 0.0006
306 CARDIAC TAMPONADE 3 0.0006
307 SLEEP DISORDER 44 0.0006
308 VENTRICULAR HYPOKINESIA 2 0.0006
309 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
310 AORTIC VALVE DISEASE 1 0.0006
311 HYPOVENTILATION 2 0.0006
312 HICCUPS 5 0.0006
313 PROTEIN URINE PRESENT 3 0.0006
314 CARDIAC FAILURE ACUTE 4 0.0006
315 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
316 DYSPHORIA 3 0.0006
317 ATAXIA 7 0.0006
318 TACHYPNOEA 8 0.0006
319 NEUTROPHIL COUNT INCREASED 6 0.0006
320 RENAL IMPAIRMENT 49 0.0006
321 REGURGITATION 2 0.0006
322 BLOOD CHLORIDE INCREASED 1 0.0006
323 TACHYPHRENIA 2 0.0006
324 DELIRIUM 20 0.0006
325 CAROTID ARTERY STENOSIS 2 0.0006
326 RESPIRATORY DEPRESSION 7 0.0006
327 THROMBOPHLEBITIS 2 0.0006
328 ALOPECIA AREATA 1 0.0006
329 HALLUCINATION, VISUAL 12 0.0006
330 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
331 HYPERTENSION 120 0.0006
332 JAUNDICE CHOLESTATIC 2 0.0006
333 NYSTAGMUS 3 0.0006
334 GLOSSITIS 2 0.0006
335 DYSARTHRIA 21 0.0006
336 POISONING 7 0.0006
337 DIABETES MELLITUS 42 0.0006
338 MONOCYTE COUNT INCREASED 2 0.0006
339 ASPIRATION 6 0.0005
340 HYPOPHAGIA 14 0.0005
341 MAJOR DEPRESSION 4 0.0005
342 CEREBRAL DISORDER 4 0.0005
343 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
344 INTRACRANIAL PRESSURE INCREASED 3 0.0005
345 BLOOD UREA INCREASED 9 0.0005
346 ERYTHEMA MULTIFORME 5 0.0005
347 BLOOD IRON INCREASED 1 0.0005
348 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
349 STATUS EPILEPTICUS 6 0.0005
350 PROTEIN TOTAL DECREASED 2 0.0005
351 HEPATIC NECROSIS 2 0.0005
352 MITRAL VALVE INCOMPETENCE 6 0.0005
353 BLOOD BICARBONATE DECREASED 1 0.0005
354 BILE DUCT OBSTRUCTION 1 0.0005
355 MICTURITION URGENCY 6 0.0005
356 HYPERTONIA 3 0.0005
357 COMMUNICATION DISORDER 2 0.0005
358 OESOPHAGEAL DISORDER 2 0.0005
359 RESTLESSNESS 19 0.0005
360 HYPERTRIGLYCERIDAEMIA 3 0.0005
361 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
362 BRADYCARDIA 27 0.0005
363 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
364 LETHARGY 29 0.0005
365 TRICUSPID VALVE INCOMPETENCE 4 0.0005
366 SKIN PAPILLOMA 2 0.0005
367 BRAIN INJURY 5 0.0005
368 LEUKOCYTOSIS 9 0.0005
369 TREATMENT FAILURE 41 0.0005
370 GALLBLADDER OPERATION 2 0.0005
371 HOMICIDAL IDEATION 2 0.0005
372 CARDIOMEGALY 6 0.0005
373 ANAPHYLACTOID REACTION 2 0.0005
374 HYPOKINESIA 7 0.0005
375 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
376 PNEUMONIA ASPIRATION 12 0.0005
377 GASTROINTESTINAL DISORDER 43 0.0005
378 EOSINOPHIL COUNT INCREASED 4 0.0005
379 HALLUCINATION 36 0.0005
380 TREMOR 79 0.0005
381 DRUG USE DISORDER 4 0.0005
382 SLEEP APNOEA SYNDROME 9 0.0005
383 AORTIC VALVE INCOMPETENCE 2 0.0005
384 ANAEMIA MACROCYTIC 1 0.0005
385 PURULENT DISCHARGE 2 0.0005
386 ERECTILE DYSFUNCTION 12 0.0005
387 DRUG RESISTANCE 12 0.0005
388 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
389 TREATMENT NONCOMPLIANCE 25 0.0005
390 DYSGRAPHIA 3 0.0005
391 HAEMORRHAGIC ANAEMIA 2 0.0005
392 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
393 POST-TRAUMATIC STRESS DISORDER 3 0.0004
394 DRUG INTOLERANCE 43 0.0004
395 ANAL INCONTINENCE 4 0.0004
396 HYPOTENSION 88 0.0004
397 EYE OPERATION 2 0.0004
398 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
399 THINKING ABNORMAL 8 0.0004
400 ABNORMAL BEHAVIOUR 17 0.0004
401 UNRESPONSIVE TO STIMULI 11 0.0004
402 RENAL FAILURE ACUTE 18 0.0004
403 CARDIAC ARREST 35 0.0004
404 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
405 GESTATIONAL DIABETES 2 0.0004
406 CONSTIPATION 91 0.0004
407 SINUS BRADYCARDIA 4 0.0004
408 NOCTURIA 5 0.0004
409 OVERDOSE 88 0.0004
410 BREATH SOUNDS ABNORMAL 2 0.0004
411 FEELING DRUNK 3 0.0004
412 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
413 IMMUNODEFICIENCY 6 0.0004
414 FLUID INTAKE REDUCED 2 0.0004
415 DERMATITIS EXFOLIATIVE 2 0.0004
416 EYELID PTOSIS 4 0.0004
417 APPENDICITIS PERFORATED 1 0.0004
418 MOTOR DYSFUNCTION 4 0.0004
419 MENTAL DISORDER 17 0.0004
420 INITIAL INSOMNIA 4 0.0004
421 DYSPHAGIA 37 0.0004
422 URINARY RETENTION 13 0.0004
423 SEIZURE 45 0.0004
424 CEREBRAL ISCHAEMIA 2 0.0004
425 AORTIC ARTERIOSCLEROSIS 1 0.0004
426 TEMPERATURE INTOLERANCE 4 0.0004
427 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
428 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
429 NICOTINE DEPENDENCE 3 0.0004
430 ACTINIC KERATOSIS 1 0.0004
431 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
432 DRUG SCREEN POSITIVE 3 0.0004
433 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
434 INCONTINENCE 4 0.0004
435 AREFLEXIA 1 0.0004
436 ALCOHOL ABUSE 1 0.0004
437 HAIR TEXTURE ABNORMAL 5 0.0004
438 ABDOMINAL MASS 1 0.0004
439 FEAR 10 0.0004
440 SUICIDAL IDEATION 34 0.0004
441 BRUXISM 2 0.0004
442 DECREASED ACTIVITY 4 0.0004
443 SUBSTANCE ABUSE 3 0.0004
444 DRUG TOXICITY 5 0.0004
445 TIC 2 0.0004
446 NONSPECIFIC REACTION 2 0.0004
447 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
448 EMOTIONAL DISORDER 11 0.0004
449 PREMATURE LABOUR 2 0.0004
450 NEUTROPHILIA 2 0.0004
451 CHOLECYSTECTOMY 4 0.0003
452 NEUROLOGICAL SYMPTOM 2 0.0003
453 MYOCARDITIS 4 0.0003
454 VISUAL DISTURBANCE 2 0.0003
455 ANURIA 3 0.0003
456 CORONARY ARTERY BYPASS 2 0.0003
457 CARDIAC MURMUR 3 0.0003
458 HYSTERECTOMY 3 0.0003
459 ANHEDONIA 9 0.0003
460 SPINAL OSTEOARTHRITIS 3 0.0003
461 DECREASED INTEREST 2 0.0003
462 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
463 SYMPTOM RECURRENCE 2 0.0003
464 BLOOD CULTURE POSITIVE 1 0.0003
465 RESTLESS LEGS SYNDROME 6 0.0003
466 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
467 HYPERGLYCAEMIA 12 0.0003
468 TACHYCARDIA 29 0.0003
469 ANGER 11 0.0003
470 SPEECH DISORDER 17 0.0003
471 AGRANULOCYTOSIS 6 0.0003
472 BLOOD CHOLESTEROL INCREASED 15 0.0003
473 FALL 107 0.0003
474 BLOOD BLISTER 1 0.0003
475 SOMNOLENCE 64 0.0003
476 BILE DUCT STONE 1 0.0003
477 SCREAMING 2 0.0003
478 MYDRIASIS 4 0.0003
479 INTENTIONAL OVERDOSE 20 0.0003
480 ATELECTASIS 3 0.0003
481 ANOREXIA 4 0.0003
482 HIATUS HERNIA 4 0.0003
483 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
484 ARTHROPATHY 17 0.0003
485 POLYP 2 0.0003
486 SOMNAMBULISM 2 0.0003
487 SHOCK 7 0.0003
488 INFECTION 44 0.0003
489 PULMONARY CONGESTION 4 0.0003
490 DRUG LEVEL INCREASED 5 0.0003
491 EMPHYSEMA 3 0.0003
492 WRONG PRODUCT ADMINISTERED 2 0.0003
493 DRUG LEVEL DECREASED 3 0.0003
494 EPILEPSY 9 0.0003
495 SLUGGISHNESS 3 0.0003
496 COMA 14 0.0003
497 EAR DISCOMFORT 3 0.0003
498 VENTRICULAR EXTRASYSTOLES 3 0.0003
499 NERVOUS SYSTEM DISORDER 9 0.0003
500 PETECHIAE 3 0.0003
501 PAPULE 2 0.0003
502 DEPRESSED MOOD 15 0.0003
503 SUDDEN DEATH 3 0.0003
504 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
505 SINUS TACHYCARDIA 4 0.0003
506 BREAST PAIN 3 0.0003
507 ANGINA PECTORIS 8 0.0003
508 DISTURBANCE IN ATTENTION 15 0.0003
509 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
510 BONE LESION 1 0.0003
511 FAECES SOFT 2 0.0003
512 DRUG INEFFECTIVE 362 0.0003
513 END STAGE RENAL DISEASE 5 0.0003
514 BLOOD PHOSPHORUS DECREASED 1 0.0003
515 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
516 PSYCHIATRIC SYMPTOM 2 0.0003
517 MALNUTRITION 3 0.0003
518 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
519 PANCREATITIS 14 0.0003
520 ROAD TRAFFIC ACCIDENT 11 0.0003
521 TROPONIN INCREASED 2 0.0003
522 INSOMNIA 70 0.0003
523 MUSCULOSKELETAL STIFFNESS 23 0.0003
524 HYPERTHERMIA 2 0.0003
525 MUSCLE TWITCHING 6 0.0003
526 AGGRESSION 13 0.0003
527 GLAUCOMA 5 0.0003
528 EJECTION FRACTION DECREASED 4 0.0003
529 APNOEA 2 0.0003
530 CHOKING 5 0.0003
531 SEXUAL DYSFUNCTION 3 0.0003
532 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
533 AFFECTIVE DISORDER 2 0.0003
534 DISABILITY 5 0.0003
535 DISORIENTATION 10 0.0003
536 HYPERLIPIDAEMIA 3 0.0003
537 DIABETIC KETOACIDOSIS 6 0.0002
538 BLOOD DISORDER 2 0.0002
539 BLEPHARITIS 1 0.0002
540 INTENTIONAL SELF-INJURY 5 0.0002
541 C-REACTIVE PROTEIN INCREASED 9 0.0002
542 POLYURIA 2 0.0002
543 HYPERSOMNIA 7 0.0002
544 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
545 SPINAL COMPRESSION FRACTURE 2 0.0002
546 APPLICATION SITE IRRITATION 3 0.0002
547 HYPERHIDROSIS 31 0.0002
548 HEMIPLEGIA 2 0.0002
549 ACCIDENTAL EXPOSURE 1 0.0002
550 ATRIAL SEPTAL DEFECT 2 0.0002
551 WITHDRAWAL SYNDROME 10 0.0002
552 KNEE ARTHROPLASTY 5 0.0002
553 EATING DISORDER 5 0.0002
554 HEPATIC ENZYME INCREASED 16 0.0002
555 IMPAIRED WORK ABILITY 5 0.0002
556 MULTI-ORGAN FAILURE 4 0.0002
557 PLATELET COUNT INCREASED 3 0.0002
558 BONE CANCER 1 0.0002
559 CONFUSIONAL STATE 37 0.0002
560 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
561 DRUG WITHDRAWAL SYNDROME 20 0.0002
562 ORAL CANDIDIASIS 3 0.0002
563 LUNG INFILTRATION 2 0.0002
564 PURPURA 2 0.0002
565 PULMONARY OEDEMA 10 0.0002
566 DRUG-INDUCED LIVER INJURY 7 0.0002
567 CRYING 8 0.0002
568 RESPIRATORY FAILURE 16 0.0002
569 METABOLIC ACIDOSIS 7 0.0002
570 RETINAL DETACHMENT 2 0.0002
571 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
572 IRON DEFICIENCY ANAEMIA 2 0.0002
573 JOINT SWELLING 26 0.0002
574 DEPRESSION 49 0.0002
575 PERSONALITY CHANGE 2 0.0002
576 HEPATIC STEATOSIS 4 0.0002
577 HEPATIC ENCEPHALOPATHY 2 0.0002
578 NEPHROPATHY 2 0.0002
579 DIARRHOEA HAEMORRHAGIC 2 0.0002
580 OXYGEN SATURATION DECREASED 12 0.0002
581 FLANK PAIN 2 0.0002
582 ANXIETY 60 0.0002
583 DRY MOUTH 17 0.0002
584 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
585 HYPERCHOLESTEROLAEMIA 2 0.0002
586 MENTAL IMPAIRMENT 5 0.0002
587 DIZZINESS POSTURAL 2 0.0002
588 EAR PAIN 4 0.0002
589 OFF LABEL USE 180 0.0002
590 INFLAMMATORY BOWEL DISEASE 2 0.0002
591 COELIAC DISEASE 2 0.0002
592 LABORATORY TEST ABNORMAL 6 0.0002
593 BODY TEMPERATURE DECREASED 2 0.0002
594 CARDIOMYOPATHY 3 0.0002
595 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
596 LIGAMENT SPRAIN 2 0.0002
597 HYPOTONIA 2 0.0002
598 APHASIA 6 0.0002
599 PRODUCT PHYSICAL ISSUE 4 0.0002
600 BLOOD COUNT ABNORMAL 3 0.0002
601 CHRONIC KIDNEY DISEASE 15 0.0002
602 PLEURAL EFFUSION 12 0.0002
603 DRY THROAT 2 0.0002
604 AMMONIA INCREASED 1 0.0002
605 HEPATITIS 5 0.0002
606 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
607 MUSCULOSKELETAL CHEST PAIN 3 0.0002
608 ANKLE FRACTURE 3 0.0002
609 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
610 TENDERNESS 2 0.0002
611 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
612 CYANOSIS 3 0.0002
613 BRONCHITIS 14 0.0002
614 URINARY TRACT INFECTION 32 0.0002
615 POOR QUALITY SLEEP 4 0.0002
616 BEHAVIOUR DISORDER 1 0.0002
617 THROAT TIGHTNESS 5 0.0002
618 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
619 SKIN LACERATION 2 0.0002
620 PULMONARY THROMBOSIS 2 0.0002
621 AUTISM SPECTRUM DISORDER 1 0.0002
622 ABNORMAL DREAMS 5 0.0002
623 FEELING COLD 5 0.0002
624 LOSS OF CONSCIOUSNESS 23 0.0002
625 PERICARDITIS 3 0.0002
626 DYSPNOEA 101 0.0002
627 SKIN INFECTION 2 0.0002
628 INTESTINAL PERFORATION 2 0.0002
629 OCULAR DISCOMFORT 2 0.0002
630 PANCREATITIS ACUTE 4 0.0002
631 HYPERSENSITIVITY 33 0.0002
632 IMPAIRED DRIVING ABILITY 2 0.0002
633 CONVULSION 10 0.0002
634 MUSCULOSKELETAL DISCOMFORT 3 0.0002
635 NEOPLASM 2 0.0002
636 PRODUCT SUBSTITUTION ISSUE 10 0.0002
637 NIGHTMARE 6 0.0002
638 BLOOD URIC ACID INCREASED 1 0.0002
639 PERICARDIAL EFFUSION 4 0.0002
640 LIVER FUNCTION TEST ABNORMAL 5 0.0002
641 NEUTROPHIL COUNT DECREASED 7 0.0002
642 SPLENOMEGALY 2 0.0002
643 SPINAL PAIN 2 0.0002
644 HEAD DISCOMFORT 3 0.0002
645 HOSPITALISATION 26 0.0002
646 ARRHYTHMIA 8 0.0002
647 GALLBLADDER DISORDER 3 0.0002
648 THIRST 3 0.0002
649 POLLAKIURIA 7 0.0002
650 PAIN 103 0.0002
651 CARDIO-RESPIRATORY ARREST 7 0.0002
652 RESPIRATORY DISORDER 5 0.0002
653 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
654 GAIT DISTURBANCE 31 0.0002
655 GENERALISED OEDEMA 2 0.0002
656 NECK PAIN 9 0.0002
657 BACTERIAL INFECTION 3 0.0002
658 HEPATIC FUNCTION ABNORMAL 6 0.0002
659 TOOTH EXTRACTION 2 0.0002
660 INTENTIONAL PRODUCT MISUSE 14 0.0002
661 BLEPHAROSPASM 1 0.0002
662 MYALGIA 27 0.0002
663 FOOT FRACTURE 3 0.0002
664 HEAD INJURY 5 0.0002
665 PULMONARY EMBOLISM 15 0.0002
666 INJURY 11 0.0002
667 INFLAMMATION 8 0.0002
668 NODULE 2 0.0002
669 NERVOUSNESS 8 0.0002
670 OSTEONECROSIS 5 0.0002
671 BEDRIDDEN 2 0.0002
672 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
673 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
674 VISUAL ACUITY REDUCED 5 0.0002
675 FUNGAL INFECTION 5 0.0001
676 SKIN DISORDER 5 0.0001
677 RHEUMATOID ARTHRITIS 17 0.0001
678 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
679 MENSTRUATION IRREGULAR 4 0.0001
680 QUALITY OF LIFE DECREASED 2 0.0001
681 DRUG EFFECT DECREASED 8 0.0001
682 THERAPEUTIC RESPONSE DECREASED 9 0.0001
683 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
684 BODY TEMPERATURE INCREASED 3 0.0001
685 MOOD ALTERED 4 0.0001
686 HAEMATURIA 5 0.0001
687 HYPOGLYCAEMIA 7 0.0001
688 ORAL DISCOMFORT 2 0.0001
689 RHABDOMYOLYSIS 6 0.0001
690 MYOCARDIAL INFARCTION 25 0.0001
691 RASH MACULAR 5 0.0001
692 CARPAL TUNNEL SYNDROME 2 0.0001
693 HYPOXIA 5 0.0001
694 FEELING ABNORMAL 34 0.0001
695 BLINDNESS UNILATERAL 2 0.0001
696 CONDITION AGGRAVATED 43 0.0001
697 SEASONAL ALLERGY 2 0.0001
698 ASTHENIA 53 0.0001
699 CELLULITIS 7 0.0001
700 MEMORY IMPAIRMENT 19 0.0001
701 INJECTION SITE HAEMATOMA 2 0.0001
702 DRUG EFFECT INCOMPLETE 5 0.0001
703 FATIGUE 107 0.0001
704 PANIC ATTACK 5 0.0001
705 DYSSTASIA 4 0.0001
706 ACCIDENTAL OVERDOSE 5 0.0001
707 DIARRHOEA 88 0.0001
708 RENAL FAILURE 18 0.0001
709 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
710 LIVER DISORDER 6 0.0001
711 ARTHROPOD BITE 1 0.0001
712 SKIN HAEMORRHAGE 2 0.0001
713 RENAL INJURY 4 0.0001
714 PULMONARY MASS 2 0.0001
715 COLON CANCER 2 0.0001
716 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
717 HEPATIC FAILURE 4 0.0001
718 LACRIMATION INCREASED 4 0.0001
719 CORONARY ARTERY DISEASE 4 0.0001
720 PRODUCT AVAILABILITY ISSUE 3 0.0001
721 INSURANCE ISSUE 2 0.0001
722 SYNCOPE 13 0.0001
723 TENDONITIS 2 0.0001
724 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
725 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
726 SCIATICA 2 0.0001
727 ATRIAL FLUTTER 1 0.0001
728 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
729 EYE PAIN 7 0.0001
730 EMOTIONAL DISTRESS 15 0.0001
731 VISION BLURRED 17 0.0001
732 FIBROMYALGIA 3 0.0001
733 OEDEMA PERIPHERAL 15 0.0001
734 NAUSEA 97 0.0001
735 ASPHYXIA 1 0.0001
736 ADVERSE DRUG REACTION 11 0.0001
737 MULTIPLE FRACTURES 2 0.0001
738 OSTEOPOROSIS 5 0.0001
739 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
740 LIP SWELLING 4 0.0001
741 COAGULOPATHY 2 0.0001
742 NASAL CONGESTION 7 0.0001
743 CHEST PAIN 22 0.0001
744 FACE OEDEMA 2 0.0001
745 WEIGHT DECREASED 33 0.0001
746 NEUTROPENIA 16 0.0001
747 CATARACT 7 0.0001
748 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
749 BLOOD MAGNESIUM DECREASED 1 0.0001
750 HAEMATOMA 3 0.0001
751 RESPIRATORY TRACT INFECTION 3 0.0001
752 JOINT STIFFNESS 3 0.0001
753 DIZZINESS 57 0.0001
754 SYRINGE ISSUE 2 0.0001
755 HYPERKALAEMIA 4 0.0001
756 BLOOD CALCIUM INCREASED 1 0.0001
757 GASTRITIS 3 0.0001
758 COLD SWEAT 2 0.0001
759 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
760 DRUG ERUPTION 2 0.0001
761 PAIN IN EXTREMITY 33 0.0001
762 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
763 BLOOD PRESSURE INCREASED 17 0.0001
764 ACUTE KIDNEY INJURY 17 0.0001
765 HEART RATE INCREASED 11 0.0001
766 RASH PRURITIC 6 0.0001
767 VOMITING 52 0.0001
768 TOOTHACHE 2 0.0001
769 OSTEOMYELITIS 2 0.0001
770 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
771 PYREXIA 38 0.0001
772 BONE DISORDER 2 0.0001
773 DRUG DOSE OMISSION 18 0.0001
774 RESPIRATORY ARREST 3 0.0001
775 DYSURIA 4 0.0001
776 RHINORRHOEA 7 0.0001
777 MEDICATION ERROR 6 0.0001
778 CONJUNCTIVITIS 2 0.0001
779 SWELLING FACE 7 0.0001
780 RENAL DISORDER 5 0.0001
781 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
782 HEPATIC CIRRHOSIS 2 0.0001
783 PHOTOPHOBIA 2 0.0001
784 ARTERIOSCLEROSIS 1 0.0001
785 ARTHRALGIA 44 0.0001
786 MUSCULAR WEAKNESS 12 0.0001
787 ABDOMINAL DISTENSION 11 0.0001
788 PROTEINURIA 2 0.0001
789 FEELING JITTERY 2 0.0001
790 MIGRAINE 10 0.0001
791 CHOLESTASIS 2 0.0001
792 HERNIA 2 0.0001
793 ERUCTATION 2 0.0001
794 AUTOIMMUNE DISORDER 1 0.0001
795 ORAL HERPES 2 0.0001
796 PNEUMONIA 33 0.0001
797 ACUTE MYOCARDIAL INFARCTION 3 0.0001
798 SINUS DISORDER 2 0.0001
799 HAEMATOCRIT DECREASED 2 0.0001
800 PRESCRIBED UNDERDOSE 2 0.0001
801 SPINAL FRACTURE 2 0.0001
802 BLOOD POTASSIUM DECREASED 3 0.0001
803 FULL BLOOD COUNT DECREASED 2 0.0001
804 PRODUCT ADMINISTRATION ERROR 2 0.0001
805 ILL-DEFINED DISORDER 6 0.0001
806 FEEDING DISORDER 2 0.0001
807 CHEST DISCOMFORT 10 0.0001
808 RIB FRACTURE 2 0.0001
809 GYNAECOMASTIA 3 0.0001
810 TOOTH LOSS 2 0.0001
811 SWELLING 9 0.0001
812 PULMONARY HYPERTENSION 2 0.0001
813 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
814 BLOOD GLUCOSE INCREASED 18 0.0001
815 MOUTH ULCERATION 2 0.0001
816 CYSTITIS 3 0.0001
817 MOOD SWINGS 3 0.0001
818 HYPOTHYROIDISM 3 0.0001
819 CHILLS 11 0.0001
820 JOINT INJURY 2 0.0001
821 BODY HEIGHT DECREASED 1 0.0001
822 IRRITABLE BOWEL SYNDROME 2 0.0001
823 UNEVALUABLE EVENT 7 0.0001
824 PRODUCT DISPENSING ERROR 2 0.0001
825 ALOPECIA 18 0.0001
826 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
827 STAPHYLOCOCCAL INFECTION 3 0.0001
828 DECREASED APPETITE 21 0.0001
829 VIRAL INFECTION 3 0.0001
830 TRANSAMINASES INCREASED 2 0.0001
831 GAIT INABILITY 3 0.0001
832 ORAL PAIN 2 0.0001
833 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
834 HEART RATE IRREGULAR 2 0.0001
835 CARDIAC FAILURE CONGESTIVE 7 0.0001
836 ADVERSE EVENT 8 0.0001
837 MALAISE 38 0.0001
838 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
839 BACTERAEMIA 1 0.0001
840 PRODUCTIVE COUGH 4 0.0001
841 BLOOD PRESSURE FLUCTUATION 2 0.0001
842 CONTUSION 8 0.0001
843 CEREBRAL INFARCTION 2 0.0001
844 BACK PAIN 19 0.0001
845 LUNG DISORDER 4 0.0001
846 LIVER INJURY 2 0.0001
847 INJECTION SITE MASS 3 0.0001
848 ABASIA 2 0.0001
849 OSTEONECROSIS OF JAW 2 0.0001
850 DYSGEUSIA 6 0.0001
851 INFLUENZA 9 0.0001
852 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
853 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
854 HAEMATEMESIS 2 0.0001
855 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
856 THERAPY CESSATION 4 0.0001
857 ABDOMINAL PAIN UPPER 16 0.0001
858 DIPLOPIA 2 0.0001
859 AMNESIA 5 0.0001
860 PALPITATIONS 9 0.0001
861 ANKYLOSING SPONDYLITIS 1 0.0001
862 OROPHARYNGEAL PAIN 7 0.0001
863 BLOOD PRESSURE DECREASED 5 0.0001
864 EAR INFECTION 2 0.0001
865 PLATELET COUNT DECREASED 8 0.0001
866 HEADACHE 47 0.0001
867 BREAST CANCER FEMALE 2 0.0001
868 ABORTION SPONTANEOUS 3 0.0001
869 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
870 PRODUCT USE ISSUE 14 0.0001
871 JAUNDICE 2 0.0001
872 PSORIATIC ARTHROPATHY 3 0.0001
873 LIMB INJURY 2 0.0001
874 BLINDNESS 3 0.0001
875 NEUROPATHY PERIPHERAL 7 0.0001
876 RESPIRATORY DISTRESS 2 0.0001
877 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
878 PROCEDURAL PAIN 2 0.0001
879 URTICARIA 12 0.0001
880 DEVICE MALFUNCTION 5 0.0001
881 MUSCLE SPASMS 13 0.0001
882 PAIN IN JAW 2 0.0001
883 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
884 RED BLOOD CELL COUNT DECREASED 2 0.0001
885 PARAESTHESIA 11 0.0001
886 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
887 ABDOMINAL PAIN 16 0.0001
888 UNDERDOSE 5 0.0001
889 DYSPHONIA 4 0.0001
890 SINUSITIS 7 0.0001
891 BONE PAIN 4 0.0001
892 HAEMOGLOBIN DECREASED 7 0.0001
893 ANAEMIA 13 0.0001
894 ASCITES 2 0.0001
895 ANGIOEDEMA 3 0.0001
896 DEHYDRATION 9 0.0001
897 PREMATURE BABY 2 0.0001
898 PRODUCT QUALITY ISSUE 9 0.0001
899 NEPHROLITHIASIS 3 0.0001
900 TINNITUS 3 0.0001
901 HYPOKALAEMIA 3 0.0001
902 CEREBROVASCULAR ACCIDENT 11 0.0001
903 EXPOSURE DURING PREGNANCY 4 0.0001
904 BONE DENSITY DECREASED 2 0.0001
905 ARTHRITIS 5 0.0001
906 OCULAR HYPERAEMIA 3 0.0001
907 BLOOD GLUCOSE DECREASED 3 0.0001
908 DRUG DEPENDENCE 10 0.0001
909 THROMBOSIS 5 0.0001
910 BACK DISORDER 1 0.0001
911 CHOLELITHIASIS 2 0.0001
912 IMPAIRED HEALING 2 0.0001
913 EYE DISORDER 2 0.0001
914 EXPIRED PRODUCT ADMINISTERED 2 0.0001
915 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
916 ECZEMA 3 0.0001
917 MUSCULOSKELETAL PAIN 3 0.0001
918 COUGH 16 0.0001
919 VISUAL IMPAIRMENT 7 0.0001
920 THERAPY INTERRUPTED 4 0.0001
921 CEREBRAL HAEMORRHAGE 2 0.0001
922 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
923 NASOPHARYNGITIS 10 0.0001
924 BLOOD GLUCOSE ABNORMAL 1 0.0001
925 SEPSIS 6 0.0001
926 ABDOMINAL DISCOMFORT 9 0.0001
927 INTESTINAL OBSTRUCTION 2 0.0001
928 BLOOD SODIUM DECREASED 1 0.0001
929 COLITIS 2 0.0001
930 ACUTE RESPIRATORY FAILURE 1 0.0001
931 WHEEZING 3 0.0001
932 BLOOD PRESSURE ABNORMAL 1 0.0001
933 CARDIAC FAILURE 4 0.0000
934 VERTIGO 3 0.0000
935 ERYTHEMA 10 0.0000
936 ILLNESS 5 0.0000
937 PRURITUS 18 0.0000
938 HYPOAESTHESIA 7 0.0000
939 HYPOACUSIS 2 0.0000
940 DEEP VEIN THROMBOSIS 3 0.0000
941 COVID-19 8 0.0000
942 PERIPHERAL SWELLING 7 0.0000
943 APPLICATION SITE PAIN 1 0.0000
944 DEATH 39 0.0000
945 THERAPY NON-RESPONDER 2 0.0000
946 ASTHMA 5 0.0000
947 RASH ERYTHEMATOUS 2 0.0000
948 MULTIPLE SCLEROSIS 2 0.0000
949 ATRIAL FIBRILLATION 4 0.0000
950 INJECTION SITE ERYTHEMA 5 0.0000
951 AGEUSIA 1 0.0000
952 ABDOMINAL PAIN LOWER 1 0.0000
953 FLUSHING 4 0.0000
954 INJECTION SITE SWELLING 3 0.0000
955 INJECTION SITE PAIN 12 0.0000
956 INJECTION SITE BRUISING 3 0.0000
957 DRY SKIN 5 0.0000
958 BLOOD BILIRUBIN INCREASED 1 0.0000
959 OEDEMA 2 0.0000
960 DEPENDENCE 2 0.0000
961 INFLUENZA LIKE ILLNESS 3 0.0000
962 HAEMATOCHEZIA 2 0.0000
963 FLATULENCE 2 0.0000
964 HERPES ZOSTER 2 0.0000
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
966 RASH 15 0.0000
967 SURGERY 2 0.0000
968 PRODUCT DOSE OMISSION ISSUE 10 0.0000
969 DISEASE PROGRESSION 4 0.0000
970 PRODUCT DOSE OMISSION 2 0.0000
971 PSORIASIS 4 0.0000
972 DYSPEPSIA 3 0.0000
973 INFUSION RELATED REACTION 2 0.0000
974 NEOPLASM MALIGNANT 2 0.0000
975 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
976 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
977 INJECTION SITE REACTION 2 0.0000
978 HAEMORRHAGE 3 0.0000
979 SKIN BURNING SENSATION 2 0.0000
980 HOT FLUSH 2 0.0000
981 INJECTION SITE HAEMORRHAGE 2 0.0000
982 DEVICE ISSUE 2 0.0000
983 NO ADVERSE EVENT 4 0.0000
984 BREAST CANCER 2 0.0000
985 ANAPHYLACTIC REACTION 1 0.0000
986 THROMBOCYTOPENIA 2 0.0000
987 BLISTER 1 0.0000
988 ACNE 1 0.0000
989 INCORRECT DOSE ADMINISTERED 3 0.0000
990 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000